ダウンロード数: 257
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
36_535.pdf | 383.94 kB | Adobe PDF | 見る/開く |
完全メタデータレコード
DCフィールド | 値 | 言語 |
---|---|---|
dc.contributor.author | 北村, 康男 | ja |
dc.contributor.author | 渡辺, 学 | ja |
dc.contributor.author | 小松原, 秀一 | ja |
dc.contributor.author | 坂田, 安之輔 | ja |
dc.contributor.alternative | Kitamura, Yasuo | en |
dc.contributor.alternative | Watanabe, Manabu | en |
dc.contributor.alternative | Komatsubara, Syuichi | en |
dc.contributor.alternative | Sakata, Yasunosuke | en |
dc.date.accessioned | 2010-06-01T02:13:27Z | - |
dc.date.available | 2010-06-01T02:13:27Z | - |
dc.date.issued | 1990-05 | - |
dc.identifier.issn | 0018-1994 | - |
dc.identifier.uri | http://hdl.handle.net/2433/116910 | - |
dc.description.abstract | Urinary excretion of glycine.prolile dipeptidile aminopeptidase (GP-DAP), N-acetyl-beta-D-glucosaminidase (NAG), alanine aminopeptidase (AAP) and beta 2-microglobulin (beta 2-M), alpha 1-microglobulin (alpha 1-M) was studied preoperatively in 32 patients with renal cell carcinoma. The excretion indices of GP-DAP, AAP and NAG were significantly higher than those in the healthy control group. The excretion of these enzymes obviously reflected the degree of the tumor progression. However, positive rates were not remarkable (37% for GP-DAP, 37% for AAP and 28% for NAG). The excretion of beta 2-M and alpha 1-M was not increased in renal cell carcinoma patients. | en |
dc.format.mimetype | application/pdf | - |
dc.language.iso | jpn | - |
dc.publisher | 泌尿器科紀要刊行会 | ja |
dc.subject | Renal cell carcinoma | en |
dc.subject | Urinary tumor marker | en |
dc.subject | GP-DAP | en |
dc.subject | AAP | en |
dc.subject | NAG | en |
dc.subject.ndc | 494.9 | - |
dc.title | 腎細胞癌症例における尿中Glycine・Prolile dipeptidileaminopeptidase, N-Acetyl-β-D-glucosaminidase, Alanineaminopeptidaseおよび低分子蛋白排泄量の検討 | ja |
dc.title.alternative | Urinary excretion of glycine.prolile dipeptidile aminopeptidase, N-acetyl-beta-D-glucosaminidase, alanine aminopeptidase and low molecular protein in patients with renal cell carcinoma | en |
dc.type | departmental bulletin paper | - |
dc.type.niitype | Departmental Bulletin Paper | - |
dc.identifier.ncid | AN00208315 | - |
dc.identifier.jtitle | 泌尿器科紀要 | ja |
dc.identifier.volume | 36 | - |
dc.identifier.issue | 5 | - |
dc.identifier.spage | 535 | - |
dc.identifier.epage | 539 | - |
dc.textversion | publisher | - |
dc.sortkey | 03 | - |
dc.address | 県立がんセンター新潟病院泌尿器科 | ja |
dc.address | 県立がんセンター新潟病院泌尿器科 | ja |
dc.address | 県立がんセンター新潟病院泌尿器科 | ja |
dc.address | 県立がんセンター新潟病院泌尿器科 | ja |
dc.address.alternative | the Department of Urology, Niigata Cancer Center Hospital, | en |
dc.address.alternative | the Department of Urology, Niigata Cancer Center Hospital, | en |
dc.address.alternative | the Department of Urology, Niigata Cancer Center Hospital, | en |
dc.address.alternative | the Department of Urology, Niigata Cancer Center Hospital, | en |
dc.identifier.pmid | 1698011 | - |
dcterms.accessRights | open access | - |
dc.identifier.pissn | 0018-1994 | - |
dc.identifier.jtitle-alternative | Acta urologica Japonica | la |
dc.identifier.jtitle-alternative | Hinyokika Kiyo | en |
出現コレクション: | Vol.36 No.5 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。